(1)
Hussain, M.; Atif, M. .; Babar, M.; Akhtar, L. COMPARISON OF EFFICACY AND SAFETY PROFILE OF EMPAGLIFLOZIN VERSUS DAPAGLIFLOZIN AS ADD ON THERAPY IN TYPE 2 DIABETIC PATIENTS. J Ayub Med Coll Abbottabad 2021, 33, 593-597.